Knowledge-based approach to identify key determinants of cisplatin sensitivity

Int J Clin Pharmacol Ther. 2017 Aug;55(8):686-689. doi: 10.5414/CPXCES15EA04.
No abstract available

MeSH terms

  • A549 Cells
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Cell Line, Tumor
  • Cisplatin / therapeutic use*
  • Humans
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Transcriptome / drug effects
  • Transcriptome / genetics

Substances

  • Antineoplastic Agents
  • Cisplatin